Divya Kumari

Divya Kumari

Auto-generated profile, based on publicly available information

Divya Kumari

Department of Pediatrics Medicine Post Graduate Institute of Medical Education and Research Chandigarh India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
ALAlice B.M. Lanne
Alice B.M. Lanne
AGAlice Goode
Alice Goode
CPCharlotte Prattley
Charlotte Prattley
DKDivya Kumari
Divya Kumari
MDMette Ryun Drasbek
Mette Ryun Drasbek
BBBoyan B. Bonev
Boyan B. Bonev

29 September 2022 in Clinical Genetics
Verified
Journal Article
Closed access
NSNandita Sharma
Nandita Sharma
DKDivya Kumari
Divya Kumari
IPInusha Panigrahi
Inusha Panigrahi
PKPreeti Khetarpal
Preeti Khetarpal

28 July 2021 in Journal of Pediatric Genetics
Verified
Journal Article
Closed access
PDF file
CCChakshu Chaudhry
Chakshu Chaudhry
DKDivya Kumari
Divya Kumari
IPInusha Panigrahi
Inusha Panigrahi
PKParminder Kaur
Parminder Kaur
Chromosome 1p36 deletion accounts for around 1% of cases of intellectual disability. The pattern of clinical features includes developmental delay, hypotonia, seizures, short stature, intellectual disability, vision and hearing deficits, congenital heart disease, and renal abnormalities. The size of deletion can be variable. We report four cases of 1p36 deletion syndrome detected in the past 3 years in a genetic clinic. One patient was detected by next-generation sequencing, another by chromosomal microarray, and the remaining two by multiplex ligation-dependent probe amplification. We discuss the variable presentations in the four children. Early diagnosis enables better prognostication and further reproductive planning. * These authors contributed equally to this study. C.C.: Drafting the work and management and follow-up of patients. D.K.: Involved in molecular analysis of patients' samples and drafting of manuscript. I.P.: Revising the manuscript critically for important intellectual content, and follow-up of patients. P.K.: Management and follow-up of patients. All authors have read and approved the final version of the manuscript. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This article is in accordance with the Declaration of Helsinki. Written informed consent was taken from guardians of the patients for publication of images. Received: 01 April 2021 Accepted: 23 June 2021 Publication Date: 28 July 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany